What is needed to achieve effective and sustainable control of African animal trypanosomosis?

LJ Morrison, MP Barrett, PC Steketee, G Cecchi… - Trends in …, 2024 - cell.com
A welcome resurgence in African animal trypanosomosis (AAT) research has resulted in
advances in capabilities, foundational datasets, and understanding. Additionally, there is the …

[HTML][HTML] Animal Trypanosomiasis: Challenges and Prospects for New Vaccination Strategies

SH Pereira, FP Alves, SMR Teixeira - Microorganisms, 2024 - mdpi.com
Animal trypanosomiasis, such as nagana, surra, and dourine, represent a significant
challenge to animal health and economic development, especially in tropical and …

[HTML][HTML] The activities of suaveolol and other compounds from Hyptis suaveolens and Momordica charantia against the aetiological agents of African trypanosomiasis …

EE Oaikhena, UA Yahaya, SM Abdulsalami… - Experimental …, 2024 - Elsevier
African trypanosomiasis and malaria are among the most severe health challenges to
humans and livestock in Africa and new drugs are needed. Leaves of Hyptis suaveolens …

Antitrypanosomal and antileishmanial activity of compounds from some Nigerian plants

S Alenezi, NP Igoli, AI Gray, EE Oaikhena… - Experimental …, 2024 - Elsevier
Ten compounds, six extracts and five fractions obtained from three Nigerian plants were
assayed for their in vitro antitrypanosomal and antileishmanial activities. Each plant was …

Discovery and Development of an Advanced Lead for the Treatment of African Trypanosomiasis

K Ilbeigi, D Mabille, A Matheeussen… - ACS Infectious …, 2024 - ACS Publications
African trypanosomiasis is a widespread disease of human and veterinary importance
caused by various Trypanosoma spp. with a globally devastating impact and a need for …

[HTML][HTML] Clinical and epidemiological investigation of human infection with zoonotic parasite Trypanosoma dionisii in China

N Xu, X Zhang, H Liu, Y Xu, H Lu, L Zhao, Y He… - Journal of Infection, 2024 - Elsevier
Background Trypanosomiasis continues to pose a global threat to human health, with
human infection mainly caused by Trypanosoma brucei and Trypanosoma cruzi. Methods …

Benign-by-Design SAHA Analogues for Human and Animal Vector-Borne Parasitic Diseases

M Rossi, B Martinengo, E Diamanti… - ACS Medicinal …, 2024 - ACS Publications
The search for new drugs fulfilling One Health and Green Chemistry requirements is an
urgent call. Here, for the first time, we envisaged developing SAHA analogues by starting …

Symbiotic bacteria Sodalis glossinidius, Spiroplasma sp and Wolbachia do not favour Trypanosoma grayi coexistence in wild population of tsetse flies collected in …

YM Mfopit, E Bilgo, S Boma, MB Somda, JE Gnambani… - BMC microbiology, 2024 - Springer
Background Tsetse flies, the biological vectors of African trypanosomes, have established
symbiotic associations with different bacteria. Their vector competence is suggested to be …

Molecular characterization of trypanocide-resistant strains derived from a single field isolate of Trypanosoma evansi

DT Subekti, Z Azmi, DA Kurniawati, LT Suwanti… - Veterinary …, 2024 - Elsevier
Abstract Four strains (SB-PR, SB-RS, SB-RD, and SB-RM) of Trypanosoma evansi (T.
evansi) were used in this study. SB-PR is known to be trypanocide-sensitive, while the …

[HTML][HTML] Environmental impacts of drugs against parasitic vector-borne diseases and the need to integrate sustainability into their development and use

CM Lima, E Uliassi, ESJ Thoré… - Open Research …, 2024 - pmc.ncbi.nlm.nih.gov
Background The current scientific discourse on environmental impacts of veterinary
medicines mostly focuses on ectoparasiticides. Meanwhile, the environmental impacts of …